Literature DB >> 30214608

The function of FAK/CCDC80/E-cadherin pathway in the regulation of B16F10 cell migration.

Guoshun Pei1, Yan Lan1, Weijie Lu1, Lina Ji1, Zi-Chun Hua1,2.   

Abstract

Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase involved in the development and progression of cancer. However, the regulatory role of FAK in cell migration remains unclear. The aim of the present study was to investigate the mechanism underlying the regulation of melanoma cell migration by FAK. The effect of FAK knockdown on gene expression in B16F10 cells was examined by gene chip analysis. The expression levels of coiled-coil domain containing 80 (CCDC80) and epithelial (E)-cadherin were analyzed by reverse transcription quantitative polymerase chain reaction and western blotting. Wound healing and transwell assays were used to monitor B16F10 cell migration. It was identified that the knockdown of FAK increased the expression levels of CCDC80 and E-cadherin, while the overexpression of CCDC80 elevated E-cadherin expression. Concurrently, upregulation of CCDC80 inhibited the migration of B16F10 cells, and downregulation of CCDC80 promoted the migration of B16F10 cells. The clinical data from the Oncomine database also revealed that the mRNA level of FAK was increased while the mRNA levels of CCDC80 and E-cadherin were decreased in patients with melanoma compared with normal controls. Taken together, the results of the present study suggest that the regulation of B16F10 melanoma cell migration by FAK is potentially mediated by CCDC80.

Entities:  

Keywords:  coiled-coil domain containing 80; epithelial cadherin; focal adhesion kinase; melanoma; migration

Year:  2018        PMID: 30214608      PMCID: PMC6126219          DOI: 10.3892/ol.2018.9159

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  25 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Signaling through focal adhesion kinase.

Authors:  D D Schlaepfer; C R Hauck; D J Sieg
Journal:  Prog Biophys Mol Biol       Date:  1999       Impact factor: 3.667

Review 3.  FAK signaling in human cancer as a target for therapeutics.

Authors:  Brian Y Lee; Paul Timpson; Lisa G Horvath; Roger J Daly
Journal:  Pharmacol Ther       Date:  2014-10-12       Impact factor: 12.310

4.  Transcriptional repression of the tumor suppressor DRO1 by AIB1.

Authors:  Juan Ferragud; Alvaro Avivar-Valderas; Antoni Pla; Javier De Las Rivas; Jaime Font de Mora
Journal:  FEBS Lett       Date:  2011-08-25       Impact factor: 4.124

5.  DRO1, a gene down-regulated by oncogenes, mediates growth inhibition in colon and pancreatic cancer cells.

Authors:  Guido T Bommer; Claudia Jäger; Eva-Maria Dürr; Sebastian Baehs; Sören T Eichhorst; Thomas Brabletz; Gang Hu; Thomas Fröhlich; Georg Arnold; Dagmar C Kress; Burkhard Göke; Eric R Fearon; Frank T Kolligs
Journal:  J Biol Chem       Date:  2004-11-24       Impact factor: 5.157

6.  Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma.

Authors:  Javier Rangel; Sima Torabian; Ladan Shaikh; Mehdi Nosrati; Frederick L Baehner; Chris Haqq; Stanley P L Leong; James R Miller; Richard W Sagebiel; Mohammed Kashani-Sabet
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

7.  AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor.

Authors:  J Font de Mora; M Brown
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

8.  Cloning and molecular characterization of a novel gene strongly induced by the adenovirus E1A gene in rat thyroid cells.

Authors:  Roberta Visconti; Filippo Schepis; Rodolfo Iuliano; Giovanna Maria Pierantoni; Li Zhang; Francesca Carlomagno; Caterina Battaglia; Maria Luisa Martelli; Francesco Trapasso; Massimo Santoro; Alfredo Fusco
Journal:  Oncogene       Date:  2003-02-20       Impact factor: 9.867

Review 9.  Melanoma: molecular pathogenesis and emerging target therapies (Review).

Authors:  Alessia E Russo; Elena Torrisi; Ylenia Bevelacqua; Rosario Perrotta; Massimo Libra; James A McCubrey; Demetrios A Spandidos; Franca Stivala; Grazia Malaponte
Journal:  Int J Oncol       Date:  2009-06       Impact factor: 5.650

10.  DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma.

Authors:  Mario Venza; Maria Visalli; Teresa Catalano; Carmelo Biondo; Concetta Beninati; Diana Teti; Isabella Venza
Journal:  Oncol Rep       Date:  2016-02-11       Impact factor: 3.906

View more
  6 in total

1.  Recombinant Expression and Bioactivity Characterization of TAT-Fused Thymosin β10.

Authors:  Kunzhi Jia; Ming Lin; Defeng Kong; Qi Jia
Journal:  Protein J       Date:  2019-12       Impact factor: 2.371

2.  Bioinformatics analysis and verification of molecular targets in ovarian cancer stem-like cells.

Authors:  Abhijeet Behera; Rahail Ashraf; Amit Kumar Srivastava; Sanjay Kumar
Journal:  Heliyon       Date:  2020-09-14

3.  A Tumor Progression Related 7-Gene Signature Indicates Prognosis and Tumor Immune Characteristics of Gastric Cancer.

Authors:  Fen Liu; Zongcheng Yang; Lixin Zheng; Wei Shao; Xiujie Cui; Yue Wang; Jihui Jia; Yue Fu
Journal:  Front Oncol       Date:  2021-06-14       Impact factor: 6.244

4.  Inhibition of TGF-β signalling in combination with nal-IRI plus 5-Fluorouracil/Leucovorin suppresses invasion and prolongs survival in pancreatic tumour mouse models.

Authors:  Eunji Hong; Sujin Park; Akira Ooshima; Chang Pyo Hong; Jinah Park; Jin Sun Heo; Siyoung Lee; Haein An; Jin Muk Kang; Seok Hee Park; Joon Oh Park; Seong-Jin Kim
Journal:  Sci Rep       Date:  2020-02-19       Impact factor: 4.379

5.  Downregulation of the Coiled-Coil Domain Containing 80 and Its Perspective Mechanisms in Ovarian Carcinoma: A Comprehensive Study.

Authors:  Zi-Qian Liang; Li Gao; Jun-Hong Chen; Wen-Bin Dai; Ya-Si Su; Gang Chen
Journal:  Int J Genomics       Date:  2021-11-15       Impact factor: 2.326

6.  Loss of DRO1/CCDC80 in the tumor microenvironment promotes carcinogenesis.

Authors:  Jessica I Christian; Agnieszka Pastula; Andreas Herbst; Jens Neumann; Maximilian K Marschall; Andrea Ofner; Heike Zierahn; Marlon R Schneider; Eckhard Wolf; Michael Quante; Frank T Kolligs
Journal:  Oncotarget       Date:  2022-04-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.